ESR1 and breast neoplasm: Therefore, the comparison of established paclitaxel‐resistant breast cell lines and parental breast cell lines may provide us with a valuable model system to explore the mechanism underlying ERα‐mediated resistance to paclitaxel and other chemotherapeutic agents in breast tumour cells.